Ms. Michelle Lefler reports

AURORA CANNABIS DENIES NEWS OF ACQUISITION OF MEDLEAF THERAPEUTICS

Aurora Cannabis Inc. has become aware of misinformation posted on a news website, incorrectly stating that Aurora has agreed to acquire New Zealand-based MedLeaf Therapeutics. The company has not entered into any such agreement, has had no discussions with MedLeaf Therapeutics with respect to any business combination transaction, and has not made any statement or filed any information pertaining to any such transaction.

Earlier today before market open, Aurora filed the company's financial statements and management's discussion and analysis for the fourth quarter and fiscal year ending March 31, 2025. All information pertaining to these disclosures is available on the company's website and on SEDAR+ and EDGAR.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

We seek Safe Harbor.